ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMGN Amgen Inc

286.30
0.00 (0.00%)
Pre Market
Last Updated: 03:36:40
Delayed by 15 minutes

Period:

Draw Mode:

Volume 288
Bid Price 287.84
Ask Price 288.64
News -
Day High

Low
211.73

52 Week Range

High
329.72

Day Low
Share Name Share Symbol Market Stock Type
Amgen Inc AMGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 286.30 03:36:40
Open Price Low Price High Price Close Price Previous Close
286.30
Trades Shares Traded Average Volume 52 Week Range
27 288 - 211.73 - 329.72
Last Trade Type Quantity Price Currency
03:30:17 7 US$ 287.84 USD

Amgen (AMGN) Options Flow Summary

Overall Flow

Bullish

Net Premium

704k

Calls / Puts

358.33%

Buys / Sells

225.00%

OTM / ITM

83.33%

Sweeps Ratio

0.00%

Amgen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
153.43B 535.92M - 28.19B 6.72B 12.53 22.84
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Amgen News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AMGN Message Board. Create One! See More Posts on AMGN Message Board See More Message Board Posts

Historical AMGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week274.85286.82274.39280.462,669,16011.454.17%
1 Month278.52286.82268.17275.113,139,8567.782.79%
3 Months301.50329.72268.17291.713,054,645-15.20-5.04%
6 Months267.79329.72249.7001282.772,757,38418.516.91%
1 Year237.00329.72211.73262.422,589,37649.3020.80%
3 Years251.53329.72198.64246.652,720,92934.7713.82%
5 Years187.08329.72165.06235.132,703,57199.2253.04%

Amgen Description

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Your Recent History

Delayed Upgrade Clock